Retension Pharmaceuticals names Robert Wong chief accounting officer
RTSN•Retension Pharmaceuticals appointed Robert Wong vice president and chief accounting officer on October 21, effective November 2, 2026.
1. Appointment details
Wong most recently served as vice president of accounting at The Save Mart Companies, overseeing accounting, finance, tax and treasury. He was Cytokinetics’ vice president and chief accounting officer from 2019 to 2024.
